/Companies

VITia

Techstars '24

Boston, US · 1 known investors

Find your way into VITia

Sign up to see every warm intro you have to VITia

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the VITia team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

VITiaCARE builds personalized health plans that let patients share their conditions, medications, and health status, and communicate their needs to doctors, family, and caregivers. It includes an assistant called Kai and a rewards program, plus medication home delivery and partner deals for pharmacies, nutrition, caregivers, and health devices.

Also known as VITIA · Vitia, Inc. · VITiaCARE

Investors · 1

Techstarslisted by TechstarsBoulder · $220K

How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us

Company profile

researched Sep 2026

VITia, Inc. (VITIA, VITiaCARE) is a healthcare technology company whose core product is an "e-patient journal" mobile application for people living with chronic and complex conditions. The app lets users upload prescriptions to receive purchase and intake reminders, keep a health journal, record which treatments have been taken, track key health markers, and share their data with other app users so they can manage conditions as a team. The company frames its offering as a patient-driven ecosystem combining AI health coaching, loyalty rewards and gamification, with content areas covering diabetes, chronic kidney disease and digital-life topics published in English and Spanish.

The platform is positioned around treatment adherence, which the company describes as addressing three causes of non-adherence: education about the patient's condition, teamwork among patients, doctors, family members and caregivers, and incentives delivered through the VITia Rewards Program. On the clinical side, VITIA processes protected health information, patient-generated data from wearables and "Patient Diary" entries, and authentication data, applying AI models to produce what it calls actionable insights for patients and their physicians and to identify gaps in treatment follow-up. It states integrations with electronic health record systems such as Epic and Cerner via secure APIs, use of Microsoft Azure cloud infrastructure, and a "Privacy by Design" approach including end-to-end encryption and multi-factor authentication, managed by its CTO and Data Security Officer.

In the United States, VITIA operates in a dual capacity: as a HIPAA Business Associate when a healthcare provider invites the patient onto the platform, and as a Service Provider subject to consumer privacy commitments and the FTC Health Breach Notification Rule when individuals sign up independently. It states it does not sell health data and shares de-identified data with pharmaceutical or research partners only on explicit opt-in.

Founding story

The company was started by a team of five cofounders who state they encountered chronic-disease adherence problems in their own families; collectively they cite over 40 years of experience in healthcare and over 20 years in loyalty programs.

Business model

The consumer app is free to users. The company states revenue comes from two sources: pharmaceutical companies and payors, which are interested in improved adherence to increase drug sales or avoid costly complications and in data analytics on patient and doctor behavior; and the VITia Rewards Program. It also contracts with healthcare providers and health systems under Business Associate Agreements, and may share de-identified data with pharmaceutical or research partners where patients opt in.

Free-to-patient application monetized through pharma and payor customers (adherence outcomes and data analytics) and through the VITia Rewards Program, rather than through user subscriptions.

Traction

The VITiaCare Android app shows 100+ downloads on Google Play and was last updated September 24, 2026. On EquityNet, the company listed a $500,000 funding goal with $30,000 raised (6% of goal) and $0 in additional commitments.

Latest developments

The company's blog published posts through 2026 on encryption, an invitation-only data model and chronic kidney disease, and its US and Mexican privacy notices carry an April 2026 date. The Android app was updated in September 2026.

▸Full profile — market position, technology, go-to-market, geography, history

Market position

Positions itself in the medication-adherence segment of digital health, citing a $290 billion cost of non-adherence in the US and a $125 billion market opportunity.

The company argues competing solutions address only one or two of the three drivers of non-adherence, whereas VITiaCARE combines education, teamwork and incentives. It cites prior experience reaching 92% adherence levels through human interaction and states it is working to reproduce that with AI.

Technology

A mobile application (Android app VITiaCare) plus a data platform that ingests clinical PHI, wearable-device and patient-diary data, and applies AI models to generate insights and flag treatment-follow-up gaps. The company cites integration with EHR systems including Epic and Cerner via secure APIs, hosting on Microsoft Azure, end-to-end encryption, multi-factor authentication and continuous monitoring of its integration backbone.

Go-to-market

Dual distribution: direct-to-consumer download of the free VITiaCARE app, and provider-initiated invitation where clinicians prescribe or invite patients onto the platform under Business Associate Agreements. The company also publishes a bilingual (English and Spanish) patient education blog and has sought investment through the EquityNet platform.

Patients with chronic and complex conditions such as diabetes and chronic kidney disease, along with their doctors, family members and caregivers; on the paying side, pharmaceutical companies, payors, healthcare providers and health systems.

Geography

United States and Mexico. The Google Play developer listing gives a Boston, Massachusetts address (1 Boston Pl Ste 2600) with Mexican phone contacts; the privacy center names Vitia Inc. with a headquarters address at 6633 18 Mile Rd, Sterling Heights, Michigan, and publishes separate US (HIPAA) and Mexican privacy notices. Content is offered in English and Spanish (Mexico).

History

Leadership includes a CEO, Fernando S., who previously founded Sanantia, a specialty pharmacy with a patient support program, and held country-head roles at Novartis Vaccines in Mexico and Latin America growth emerging markets and at Merck Serono Oncology, with earlier positions at Eli Lilly in Mexico. The CTO, Alejandro S., co-founded The Water Bonsai and founded d20, a digital and data strategy consultancy, with prior loyalty experience at BBVA and Club Premier. The CFO, Cesar L., spent 15 years as SVP Corporate Controller at Aeromexico. Other named executives are a VP of Media/Communication, Vanessa O., previously at Actavis/Allergan and Ferring Pharmaceuticals, and a VP, Jesica L., formerly head of patient support at Sanantia and coordinator of the Distance Medicine Program of the Ministry of Health of Mexico City.

Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Android app downloadsSep 2026100 downloads
CofoundersJan 20265 people
Funding goal (EquityNet listing)Jan 2026$500K
Funding raised so far (EquityNet listing)Jan 2026$30K
Funding remaining (EquityNet listing)Jan 2026$470K
Stated US cost of medication non-adherenceJan 2026$290B
Stated US market opportunityJan 2026$125B

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 1

Companies working in the same space as VITia.

Timeline · 2

launches, deals, and filings
Sep 2026
VITiaCare Android app updated on Google Play

The VITiaCare app, published by Vitia, Inc., received an update adding/maintaining prescription upload, intake reminders, health journal, treatment tracking, data sharing with other users and health-marker tracking.

source ↗

Apr 2026
Updated US HIPAA privacy notice and Mexican privacy notice published

VITIA published a global privacy center with a US HIPAA disclosure effective April 2026, describing its dual role as HIPAA Business Associate and Service Provider, and a Mexican Aviso de Privacidad Integral last updated April 2026.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

▸Research sources · 6

primary sources listed

6 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does VITia do?
VITia builds VITiaCARE, an AI-supported patient journal app helping people with chronic conditions improve treatment adherence.
Who are VITia's investors?
VITia's investors include Techstars.
Where is VITia headquartered?
VITia is headquartered in Boston, US.